Check Lantern Pharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$42.2M
EPS (TTM)
-1.83
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-20.5M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
74638100.00%
Compare market cap, revenue, PE, and other key metrics of Lantern Pharma Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $42.2M | -76.26% | NA | 0.00% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Lantern Pharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Lantern Pharma Inc investment value today
Current value as on today
₹1,07,767
Returns
₹7,767
(+7.77%)
Returns from Lantern Pharma Inc Stock
₹2,813 (+2.81%)
Dollar Returns*
₹4,953 (+4.95%)
Based on 8 analysts
75.00%
Buy
25.00%
Hold
0.00%
Sell
Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Lantern Pharma Inc. Average target price of $22
Get share price movements and forecasts by analysts on Lantern Pharma Inc.
What analysts predicted
81.73%UPSIDE
Target Price
$22
Current Price
$4.02
Analyzed by
8 Analysts
Target
$22.00
Lantern Pharma Inc target price $22, a slight upside of 81.73% compared to current price of $4.02. According to 8 analysts rating.
Search interest for Lantern Pharma Inc Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 133.5%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 68.4%
Price Dip
In the last 1 month, LTRN stock has moved down by -11.9%
Organisation | Lantern Pharma Inc |
Headquarters | 1920 McKinney Avenue, Dallas, TX, United States, 75201 |
Industry | Commercial Services |
CEO | Mr. Panna Sharma |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Kishor Gopaldas Bhatia Ph.D. | Chief Scientific Officer & Scientific Consultant |
Dr. Peter L. Nara D.V.M., M.S., Ph.D. | Co-Founder & Advisor |
Mr. Ernest Kitt B.S., M.S | Head of Clinical Operations |
Dr. Marc C. Chamberlain M.D. | Chief Medical Officer of Starlight Therapeutics |
Mr. Panna Sharma | President, CEO & Director |
Mr. David R. Margrave | CFO & Secretary |
Lantern Pharma Inc share price today is $4.02 as on . Lantern Pharma Inc share today touched a day high of $4.13 and a low of $3.89.
Lantern Pharma Inc share touched a 52 week high of $6.12 on and a 52 week low of $2.55 on . Lantern Pharma Inc stock price today i.e. is trending at $4.02,which is 34.29% down from its 52 week high and 57.65% up from its 52 week low.
Lantern Pharma Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Lantern Pharma Inc (LTRN) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Lantern Pharma Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lantern Pharma Inc share’s latest price of $4.02 as on September 18, 2025 at 8:36 pm IST, you will get 2.4876 shares of Lantern Pharma Inc. Learn more about
fractional shares .
Lantern Pharma Inc stock has given -76.26% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?